Home

restaurace Tam Částečný marker immunofluorescence pdac cancer Šilink manželka věřit

Pancreatic Cancer Tumor Markers | GeneTex
Pancreatic Cancer Tumor Markers | GeneTex

Basal-like and Classical cells coexistence in pancreatic cancer revealed by  single cell analysis | bioRxiv
Basal-like and Classical cells coexistence in pancreatic cancer revealed by single cell analysis | bioRxiv

Cancers | Free Full-Text | Targeting Proliferating Tumor-Infiltrating  Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic  Cancer
Cancers | Free Full-Text | Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8+ T Cells in Pancreatic Cancer

A biomimetic pancreatic cancer on-chip reveals endothelial ablation via  ALK7 signaling | Science Advances
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling | Science Advances

Tumor-penetrating therapy for β5 integrin-rich pancreas cancer | Nature  Communications
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer | Nature Communications

Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews

Pancreatic Cancer Tumor Markers | GeneTex
Pancreatic Cancer Tumor Markers | GeneTex

Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel  fibroblast subtype associated with poor prognosis but better immunotherapy  response | Cell Discovery
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery

Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic  Cancer | Journal of Nuclear Medicine
Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer | Journal of Nuclear Medicine

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal  adenocarcinoma (PDAC), and combined immunotherapy with antibodies against  PD-L1 and CCL5 is effective in the treatment of PDAC | Signal Transduction  and
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC | Signal Transduction and

Frontiers | Pre-clinical Models of Metastasis in Pancreatic Cancer
Frontiers | Pre-clinical Models of Metastasis in Pancreatic Cancer

Development of primary human pancreatic cancer organoids, matched stromal  and immune cells and 3D tumor microenvironment models | BMC Cancer | Full  Text
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models | BMC Cancer | Full Text

Antibody-mediated blockade for galectin-3 binding protein in tumor  secretome abrogates PDAC metastasis | PNAS
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis | PNAS

Dynamic profiling of immune microenvironment during pancreatic cancer  development suggests early intervention and combination strategy of  immunotherapy - eBioMedicine
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy - eBioMedicine

Novel methods for in vitro modeling of pancreatic cancer reveal important  aspects for successful primary cell culture | BMC Cancer | Full Text
Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture | BMC Cancer | Full Text

SPARC dependent collagen deposition and gemcitabine delivery in a  genetically engineered mouse model of pancreas cancer - eBioMedicine
SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer - eBioMedicine

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell  Suppression and Maintenance of Key Gene Programs that Define the Squamous  Subtype - ScienceDirect
CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype - ScienceDirect

Stromal mesenchymal stem cells facilitate pancreatic cancer progression by  regulating specific secretory molecules through mutual cellular interaction
Stromal mesenchymal stem cells facilitate pancreatic cancer progression by regulating specific secretory molecules through mutual cellular interaction

Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor  functions in pancreatic ductal adenocarcinoma | Scientific Reports
Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma | Scientific Reports

Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic  Cancer | JACS Au
Sequence-Activated Fluorescent Nanotheranostics for Real-Time Profiling Pancreatic Cancer | JACS Au

STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment  in pancreatic cancer | Life Science Alliance
STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer | Life Science Alliance

A) Double immunofluorescence stainings of tumor samples from patients... |  Download Scientific Diagram
A) Double immunofluorescence stainings of tumor samples from patients... | Download Scientific Diagram

Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate  from Embryonic Hematopoiesis and Promote Tumor Progres
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progres

CD200 promotes immunosuppression in the pancreatic tumor microenvironment |  Journal for ImmunoTherapy of Cancer
CD200 promotes immunosuppression in the pancreatic tumor microenvironment | Journal for ImmunoTherapy of Cancer